Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cirtran (CIRX) EBITDA Margin (2017 - 2025)

Cirtran filings provide 12 years of EBITDA Margin readings, the most recent being 13.34% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 9837.0% to 13.34% in Q4 2025 year-over-year; TTM through Dec 2025 was 4.15%, a 3832.0% increase, with the full-year FY2025 number at 4.15%, up 3832.0% from a year prior.
  • EBITDA Margin hit 13.34% in Q4 2025 for Cirtran, up from 37.13% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 130.39% in Q4 2023 to a low of 1025.82% in Q4 2022.
  • Median EBITDA Margin over the past 5 years was 20.12% (2021), compared with a mean of 71.27%.
  • Biggest five-year swings in EBITDA Margin: soared 394209bps in 2021 and later crashed -100524bps in 2022.
  • Cirtran's EBITDA Margin stood at 20.57% in 2021, then crashed by -4886bps to 1025.82% in 2022, then soared by 113bps to 130.39% in 2023, then tumbled by -165bps to 85.04% in 2024, then soared by 116bps to 13.34% in 2025.
  • The last three reported values for EBITDA Margin were 13.34% (Q4 2025), 37.13% (Q3 2025), and 114.74% (Q2 2025) per Business Quant data.